Praeruptorin DCAS# 73069-28-0 |
- (-)-Praeruptorin B
Catalog No.:BCN7665
CAS No.:4970-26-7
- Praeruptorin B
Catalog No.:BCN4988
CAS No.:81740-07-0
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 73069-28-0 | SDF | Download SDF |
PubChem ID | 6450453 | Appearance | Powder |
Formula | C24H26O7 | M.Wt | 426.46 |
Type of Compound | Coumarins | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | [8,8-dimethyl-9-[(Z)-2-methylbut-2-enoyl]oxy-2-oxo-9,10-dihydropyrano[2,3-f]chromen-10-yl] (Z)-2-methylbut-2-enoate | ||
SMILES | CC=C(C)C(=O)OC1C(C(OC2=C1C3=C(C=C2)C=CC(=O)O3)(C)C)OC(=O)C(=CC)C | ||
Standard InChIKey | PNTWXEIQXBRCPS-PVRNWPCDSA-N | ||
Standard InChI | InChI=1S/C24H26O7/c1-7-13(3)22(26)29-20-18-16(11-9-15-10-12-17(25)28-19(15)18)31-24(5,6)21(20)30-23(27)14(4)8-2/h7-12,20-21H,1-6H3/b13-7-,14-8- | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Praeruptorin D exhibits antitumor and anti-inflammatory activities. 2. Praeruptorin D and E protect mice from hydrochloric acid (HCl)-induced lung injury by inhibiting PMNs influx, IL-6 release and protein exudation. 3. Praeruptorin D can significantly up-regulate CYP3A4 expression and activity via the Pregnane X receptor (PXR)-mediated pathway. |
Targets | IL Receptor | p65 | NF-kB | TNF-α | P450 (e.g. CYP17) |
Praeruptorin D Dilution Calculator
Praeruptorin D Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.3449 mL | 11.7244 mL | 23.4489 mL | 46.8977 mL | 58.6221 mL |
5 mM | 0.469 mL | 2.3449 mL | 4.6898 mL | 9.3795 mL | 11.7244 mL |
10 mM | 0.2345 mL | 1.1724 mL | 2.3449 mL | 4.6898 mL | 5.8622 mL |
50 mM | 0.0469 mL | 0.2345 mL | 0.469 mL | 0.938 mL | 1.1724 mL |
100 mM | 0.0234 mL | 0.1172 mL | 0.2345 mL | 0.469 mL | 0.5862 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- (+)-Praeruptorin A
Catalog No.:BCN4989
CAS No.:73069-27-9
- Praeruptorin A
Catalog No.:BCN4987
CAS No.:73069-25-7
- Atractylenolide II
Catalog No.:BCN1044
CAS No.:73069-14-4
- Atractylenolide I
Catalog No.:BCN1043
CAS No.:73069-13-3
- Epigomisin O
Catalog No.:BCN2862
CAS No.:73036-31-4
- Atractylenolide III
Catalog No.:BCN1045
CAS No.:73030-71-4
- CyPPA
Catalog No.:BCC7526
CAS No.:73029-73-9
- 15-Isopimarene-8,18-diol
Catalog No.:BCN4287
CAS No.:73002-86-5
- Lidocaine hydrochloride
Catalog No.:BCC9009
CAS No.:73-78-9
- Guanine
Catalog No.:BCN8414
CAS No.:73-40-5
- H-Ile-OH
Catalog No.:BCC2960
CAS No.:73-32-5
- Melatonin
Catalog No.:BCN2196
CAS No.:73-31-4
- Scutebarbatine D
Catalog No.:BCN8536
CAS No.:910099-76-2
- Arecoline
Catalog No.:BCN8537
CAS No.:73069-28-9
- Ferruginine
Catalog No.:BCN1911
CAS No.:73069-63-3
- Fenticonazole nitrate
Catalog No.:BCC8983
CAS No.:73151-29-8
- Effusol
Catalog No.:BCN2928
CAS No.:73166-28-6
- (d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin
Catalog No.:BCC6011
CAS No.:73168-24-8
- Baptifoline
Catalog No.:BCN7988
CAS No.:732-50-3
- Xamoterol hemifumarate
Catalog No.:BCC6861
CAS No.:73210-73-8
- Chloranthalactone E
Catalog No.:BCN7466
CAS No.:73215-92-6
- Remoxipride hydrochloride
Catalog No.:BCC6844
CAS No.:73220-03-8
- ITF2357 (Givinostat)
Catalog No.:BCC2150
CAS No.:732302-99-7
- Florfenicol
Catalog No.:BCC8984
CAS No.:73231-34-2
Praeruptorin D and E attenuate lipopolysaccharide/hydrochloric acid induced acute lung injury in mice.[Pubmed:23588118]
Eur J Pharmacol. 2013 Jun 15;710(1-3):39-48.
Acute lung injury is a life-threatening syndrome characterized by overwhelming lung inflammation and increased microvascular permeability, which causes a high mortality rate worldwide. The dry root of Peucedanum praeruptorum Dunn has been long used to treat respiratory diseases in China. In the present study, Praeruptorin A, C, D and E (PA, PC, PD and PE), four pyranocoumarins extracted from this herb, have been investigated for the pharmacological effects in experimental lung injury mouse models. In lipopolysaccharide (LPS) challenged mice, PA and PC did not show protective effect against lung injury at the dose of 80 mg/kg. However, PD and PE significantly inhibited the infiltration of activated polymorphonuclear leukocytes (PMNs) and decreased the levels of TNF-alpha and IL-6 in bronchoalveolar lavage fluid at the same dose. There was no statistically significant difference between PD and PE group. Further study demonstrated that PD and PE suppressed protein extravasations in bronchoalveolar lavage fluid, attenuated myeloperoxidase (MPO) activity and the pathological changes in the lung. Both PD and PE suppressed LPS induced Nuclear Factor-kappa B (NF-kappaB) pathway activation in the lung by decreasing the cytoplasmic loss of Inhibitor kappaB-alpha (IkappaB-alpha) protein and inhibiting the translocation of p65 from cytoplasm to nucleus. We also extended our study to acid-induced acute lung injury and found that these two compounds protected mice from hydrochloric acid (HCl)-induced lung injury by inhibiting PMNs influx, IL-6 release and protein exudation. Taken together, these results suggested that PD and PE might be useful in the therapy of lung injury.
Up-regulatation of CYP3A expression through pregnent X receptor by praeruptorin D isolated from Peucedanum praeruptorum Dunn.[Pubmed:23702042]
J Ethnopharmacol. 2013 Jul 9;148(2):596-602.
ETHNOPHARMACOLOGICAL RELEVANCE: Qianhu, the dried roots of Peucedanum praeruptorum DUNN (Umbelliferae), is a well-known traditional Chinese medicinal herb which was officially listed in the Chinese Pharmacopoeia. Praeruptorin D (PD) is one of the major active constituents of Peucedanum praeruptorum Dunn (Qianhu). The Pregnane X receptor (PXR) is an orphan nuclear receptor and plays a pivotal role in the activation of human cytochrome P450 3A4 (CYP3A4) gene. AIM OF THE STUDY: The purpose of this study was to investigate the effect of PD on the PXR-mediated transactivation of CYP3A4, and thus to predict potential herb-drug interactions between PD, Qianhu, and the other co-administered drugs that metabolized by CYP3A4. MATERIALS AND METHODS: The effect of PD on the Cyp3a11, mPXR mRNA expression in mice primary hepatocytes was measured using real-time PCR. The gene expression, protein expression, and catalytic activity of CYP3A4 in the LS174T cells after transfected with PXR expression plasmids were determined by real-time PCR, Western blot analysis, and LC-MS/MS based CYP3A4 substrate assay. RESULTS: The results revealed that the level of Cyp3a11 gene expression in mice primary hepatocytes was significantly increased by PD, but PD cannot induce the mPXR gene expression. On the other hand, CYP3A4 mRNA, protein expression and functional activity in PXR-over-expression LS174T cells were significantly increased by PD through PXR-mediated pathway; conversely, no significant change was found in the untransfected cells. CONCLUSIONS: These findings suggest that PD can significantly up-regulate CYP3A4 expression and activity via the PXR-mediated pathway and this should be taken into consideration to predict any potential herb-drug interactions when PD and Peucedanum praeruptorum Dunn are co-administered with other drugs.
Pharmacokinetics and tissue distribution study of Praeruptorin D from Radix peucedani in rats by high-performance liquid chromatography (HPLC).[Pubmed:22942756]
Int J Mol Sci. 2012;13(7):9129-41.
Praeruptorin D (PD), a major pyranocoumarin isolated from Radix Peucedani, exhibited antitumor and anti-inflammatory activities. The aim of this study was to investigate the pharmacokinetics and tissue distribution of PD in rats following intravenous (i.v.) administration. The levels of PD in plasma and tissues were measured by a simple and sensitive reversed-phase high-performance liquid chromatography (HPLC) method. The biosamples were treated by liquid-liquid extraction (LLE) with methyl tert-butyl ether (MTBE) and osthole was used as the internal standard (IS). The chromatographic separation was accomplished on a reversed-phase C(18) column using methanol-water (75:25, v/v) as mobile phase at a flow rate of 0.8 mL/min and ultraviolet detection wave length was set at 323 nm. The results demonstrate that this method has excellent specificity, linearity, precision, accuracy and recovery. The pharmacokinetic study found that PD fitted well into a two-compartment model with a fast distribution phase and a relative slow elimination phase. Tissue distribution showed that the highest concentration was observed in the lung, followed by heart, liver and kidney. Furthermore, PD can also be detected in the brain, which indicated that PD could cross the blood-brain barrier after i.v. administration.